Clostridium difficile is a widespread bacterium and it affects thousands of patients, posing a danger to their health and life. The costs associated with treatment are estimated at 10 to 20 billion dollars only in North America. Scientists from the University of Calgary at the National Research Council in Canada carried out a research on Clostridum difficile and expect success thanks to the use of antibodies from a llama. Read full text »